Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients

NCT02382562 | Terminated

• 1 other identifier: 2014-0340
• Study Type: interventional
• Target: 18
• Locations: 1 country
• Sites: 1

Brief Summary

Depression and other unhealthy behaviors, such as not taking medication as prescribed and not attending doctor visits have been suggested to increase the worsening of allergic diseases (e.g. asthma, urticaria). We intend to determine whether a one-session behavioral intervention is effective in helping with depression and controlling disease symptoms. We will measure this using pre- and post-intervention surveys.

Conditions

Depression; Asthma; Urticaria

Keywords

Depression; Asthma; Urticaria

Outcome Measures

Primary Outcomes (2)

• Asthma Control Test

  Changes in asthma control over a 4 week period.

  4 weeks

• Urticaria Control Test

  Changes in urticaria control over a 4 week period.

  4 weeks

Secondary Outcomes (3)

• Asthma Quality of Life Questionnaire

  4 weeks

• Urticaria Activity Score Questionnaire

  4 weeks

• Psychological Measures (Composite)

  4 weeks

Other Outcomes (1)

• Immune biomarkers

  4 weeks

Study Arms (1)

Brief Behavioral Activation Intervention

EXPERIMENTAL

All eligible participants will undergo the Brief Behavioral Activation Intervention.

Behavioral: Brief Behavioral Activation Intervention

Interventions

Brief Behavioral Activation Intervention BEHAVIORAL

Clinical psychologists (investigators) will instruct the participant in ways to become more active in life, particularly with regards to activities that the participant finds pleasurable and meaningful. The intervention will take one hour to complete. Following the intervention, the participant will receive brief, weekly text or email reminders for the next 4 weeks (total of 4) to engage in pleasurable and meaningful activities during the week.

Brief Behavioral Activation Intervention

Eligibility Criteria

• Age: 18 Years - 64 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Potential participants should be between the ages 18 and 64, seen in the UMMC Allergy Clinic with either asthma or urticaria and who report symptoms of depression in the previous 2 weeks.

You may not qualify if:

• Potential participants younger than 18 and older than 64 or who do not speak English or cannot comprehend the consent form or women who are pregnant are excluded.

Sponsors & Collaborators

• University of Mississippi Medical Center: lead

Study Sites (1)

University of Mississippi Medical Center - Allergy, Immunology and Asthma Care Clinic

Jackson, Mississippi, 39216, United States

Location

MeSH Terms

Conditions

Depression; Asthma; Urticaria

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Skin Diseases, Vascular; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Gailen D Marshall, Jr., MD, PhD

  University of Mississippi Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Gailen D. Marshall, Jr., MD, PhD

Study Record Dates

• First Submitted: March 2, 2015
• First Posted: March 6, 2015
• Study Start: May 1, 2015
• Primary Completion: March 1, 2016
• Study Completion: October 17, 2016
• Last Updated: April 19, 2018

Record last verified: 2018-04

Locations

US (1)